Moreover, FASN (fatty acid synthase), a pivotal rate-limiting enzyme in fatty acid biosynthesis, facilitates EGFR-TKI resistance by activating EGFR in the NSCLC cells. Here, FASN is linked to non-small cell lung carcinoma.